Management of polycythaemia vera: a critical review of current data
Author:
Affiliation:
1. Centre for Cancer Research and Cell Biology; Queen's University; Belfast UK
2. Departments of Cellular Pathology and Haematology; Guy's and St Thomas’ NHS Foundation Trust; London UK
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13812/fullpdf
Reference62 articles.
1. Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera;Alvarez-Larran;Blood,2012
2. WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes;Alvarez-Larran;British Journal of Haematology,2014a
3. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea;Alvarez-Larran;Annals of Hematology,2014b
4. Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes;Alvarez-Larran;European Journal of Haematology,2015
5. A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia;Andersen;British Journal of Haematology,2013
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Effect of Polycythemia Vera on Choroidal Thickness and Retrobulbar Blood Flow;Photodiagnosis and Photodynamic Therapy;2024-01
2. Differences in Clinical Outcomes Between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients;Journal of Korean Medical Science;2024
3. Concurrent Polycythemia Vera with Newly Diagnosed Multiple Myeloma: Case Report and Literature Review;Journal of Inflammation Research;2023-09
4. An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future;Frontiers in Oncology;2023-01-19
5. Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment;American Journal of Ophthalmology Case Reports;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3